v3.26.1
Segments Reporting - Schedule of Significant Expense Categories (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Significant Expense Categories [Line Items]    
Total research and development $ 182,147 $ 169,703
Total general and administrative 703,444 371,747
Other Segment (Income) Expenses 37,700 (1,833)
Net Loss 923,291 539,617
Personnel [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total research and development 162,784 142,624
Total general and administrative 146,840 72,127
Clinical and preclinical activities [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total research and development 15,733 23,449
Other [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total research and development 3,630 3,630
Professional services [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total general and administrative 427,515 201,488
Corporate expenses [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total general and administrative 92,073 60,532
Facility costs [Member]    
Schedule of Significant Expense Categories [Line Items]    
Total general and administrative $ 37,016 $ 37,600